Polycystic kidney disease gene
CA 2254083 A1 · Owner: Qian, Feng · Inventors: Germino, Gregory; Klinger, Katherine; Dackowski, William
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention involves isolated nucleic acid encoding human PKD1 and , sequences derived therefrom. The invention also encompasses vectors comprising these nucleic acids, host cells transformed with the vectors and methods for , producing PKD1 protein or fragments thereof. In another aspect the invention , involves isolated oligonucleotides that hybridize only to the authentic expressed PKD1 gene, and not to PKD1 homologues. In yet another aspect the , invention involves isolated mutant PKD1 genes and their cDNA cognates. , Further provided are isolated oligonucleotides that discriminate between normal and mutant versions of the PKD1 gene. Methods and compositions for treating …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 22, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 22, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 22, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.